PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 5 |
| 2005 | 5 |
| 2006 | 16 |
| 2007 | 39 |
| 2008 | 64 |
| 2009 | 99 |
| 2010 | 139 |
| 2011 | 86 |
| 2012 | 87 |
| 2013 | 85 |
| 2014 | 77 |
| 2015 | 91 |
| 2016 | 76 |
| 2017 | 73 |
| 2018 | 91 |
| 2019 | 104 |
| 2020 | 138 |
| 2021 | 170 |
| 2022 | 184 |
| 2023 | 168 |
| 2024 | 143 |
| 2025 | 156 |
| 2026 | 96 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Cardiovasc Res"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
One-dimensional virtual fractional flow reserve: promise, pragmatism, and next steps.
- Sykes RA, Tan D, Berry C.
- Cardiovasc Res. 2025 Nov 22;121(14):2122-2123. doi: 10.1093/cvr/cvaf193.
- PMCID: PMC12638721
Sykes RA, et al.Cardiovasc Res. 2025.PMCID: PMC12638721 -
Annexin A1: a promising target for preventing aortic dissections.
- Sawada H, Lu HS, Daugherty A.
- Cardiovasc Res. Author manuscript. 2022 May 6;118(6):1383-1384. doi: 10.1093/cvr/cvac038.
- PMCID: PMC13663894
Sawada H, et al.Cardiovasc Res. Author manuscript. 2022.PMCID: PMC13663894 -
Tirzepatide protects the heart from doxorubicin-induced cardiotoxicity by modulating endoplasmic reticulum (ER) stress and HMGCoA reductase 1 expression.
- Glembotski CC.
- Cardiovasc Res. 2025 Oct 24;121(12):1798-1800. doi: 10.1093/cvr/cvaf163.
- PMCID: PMC12551385
Glembotski CC.Cardiovasc Res. 2025.PMCID: PMC12551385 -
PKP2 orchestrates OXPHOS expression in cardiomyocytes via a PGC1α-dependent mechanism.
- Han SJ, van den Berg D, de Ruiter H, Tsui H, Kyriakopoulou E, Koopmans T, Perini I, Monshouwer-Kloots J, van Kampen SJ, Te Riele ASJM, Kelters IR, Gianoli M, Burgering BMT, van Rooij E.
- Cardiovasc Res. 2026 Oct 10;122(14):2024-2038. doi: 10.1093/cvr/cvag141.
- PMCID: PMC13653674
Han SJ, et al.Cardiovasc Res. 2026.PMCID: PMC13653674 -
Integrated management of atrial fibrillation with digital health support: a pooled analysis of individual participant data from the mAFA-II and MIRACLE-AF trials.
- Lip GYH, Chen Y, Li M, Guo Y, Chen M; mAFA-II and MIRACLE-AF Trial Investigators.
- Cardiovasc Res. 2026 Oct 10;122(14):1936-1946. doi: 10.1093/cvr/cvag173.
- PMCID: PMC13653501
Lip GYH, et al.Cardiovasc Res. 2026.PMCID: PMC13653501 -
Cytokine-associated ROS and Ca2+ dysregulation in severe inflammatory cardiomyopathy.
- Suwalski P, Golpour A, Weiner J 3rd, Musigk N, Balzer F, Giesa N, Amr A, Zyla J, Ganz P, Saleem HN, Trebing J, Sedaghat-Hamedani F, Meder B, Gold SM, Ebert A, Beule D, Landmesser U, Heidecker B.
- Cardiovasc Res. 2026 Oct 10;122(14):1978-1991. doi: 10.1093/cvr/cvag099.
- PMCID: PMC13653499
Suwalski P, et al.Cardiovasc Res. 2026.PMCID: PMC13653499 -
Inflammatory cytokines and immune signalling in heart failure: mechanisms, models, and emerging therapies.
- Mendieta G, Pironti G, Tromp J, Lund LH.
- Cardiovasc Res. 2026 Oct 10;122(14):1901-1921. doi: 10.1093/cvr/cvag172.
- PMCID: PMC13653502
Mendieta G, et al.Cardiovasc Res. 2026.PMCID: PMC13653502 -
Dual inhibition of SGLT 1 and 2 by sotagliflozin alleviates intracellular sodium overload and improves cardiometabolic remodelling in uraemic cardiomyopathy.
- Young M, Karlstaedt A, Dambure S, Miller JJJJ, Guo T, Zhou X, Ramchunder Z, Gonzalez Marques Junior J, Nobles M, Tinker A, Kim K, Purcell AR, Glastras SJ, Cullen F, Eykyn TR, Von Kriegsheim A, Rodriguez B, Campanella M, Shattock MJ, Aung N, Cabrera CP, Yaqoob MM, Aksentijevic D.
- Cardiovasc Res. 2026 Oct 10;122(14):2039-2054. doi: 10.1093/cvr/cvag167.
- PMCID: PMC13653498
Young M, et al.Cardiovasc Res. 2026.PMCID: PMC13653498 -
Liver sinusoidal endothelial cell defenestration in chronic heart failure is primarily dependent on cardiac diastolic dysfunction and is reversed by a sodium-glucose cotransporter 2 inhibitor but not by an angiotensin-converting enzyme inhibitor.
- Wojnar-Lason K, Stojak M, Kwiatkowski G, Giergiel M, Kurpinska A, Tyrankiewicz U, Pacia MZ, Kij A, Sternak M, Pacia M, Grosicki M, Zemla J, Zapotoczny B, Czyzynska-Cichon I, Chlopicki S.
- Cardiovasc Res. 2026 Oct 10;122(14):1992-2008. doi: 10.1093/cvr/cvag168.
- PMCID: PMC13653496
Wojnar-Lason K, et al.Cardiovasc Res. 2026.PMCID: PMC13653496 -
Polycystin-1 suppresses apoptotic signalling in endothelial cells and protects from atherosclerosis.
- Tardajos Ayllon B, Gras Font J, Winks TAE, Grimwood H, Roddie H, Ariaans M, Wright C, Chico TJA, Fragiadaki M, Francis SE, Ong ACM, Evans PC, Serbanovic-Canic J.
- Cardiovasc Res. 2026 Oct 10;122(14):1922-1935. doi: 10.1093/cvr/cvag171.
- PMCID: PMC13653497
Tardajos Ayllon B, et al.Cardiovasc Res. 2026.PMCID: PMC13653497